Whitepaper: Advancing cardiac drug discovery with iPSC technology

A review of current challenges and goals in cardiac drug discovery and how innovations on human iPSC technology are helping to overcome them.

Increasing the translational power of disease models or making the drug discovery process more efficient and affordable are some of the key development areas in cardiac drug discovery. Download this whitepaper to learn:

  • How iPSC technology can help find safer and more efficacious treatments
  • The benefits of phenotypic screening with human iPSC-based cardiac models
  • The latest advancements in iPSC-based solutions that contributed to find new targets and lead compounds for cardiac diseases.